NXRA yields 200000000.00% · PFE yields 6.13%● Live data
📍 NXRA pulled ahead of the other in Year 1
Combined, NXRA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXRA + PFE for your $10,000?
Nextera Enterprises, Inc., through its subsidiary, W Lab Acquisition Corp., develops and markets consumer products that offer solutions to niche personal care needs. It offers cosmetic remedies for spider veins, dark circles, blotchy skin, bruises, stretch marks, sun spots, at home microdermabrasion kit, and deep facial lines under the Vita-K Solution brand. The company, under the DermaFreeze365 brand, offers instant line relaxing formula as an anti-line and wrinkle cream for the face, neck and chest, and lip areas; and offers two anti-aging compounds: Gamma-Amino Butyric Acid, a new ingredient in modern skin care technology, and BioxiLift, which produces a cumulative reduction in the appearance of fine lines and wrinkles. It also offers Ellin LaVar Textures brand products to address the health and condition of hair and scalp, including OptiMoist Shampoo, SatinSoft Conditioner, LiquidGlass, PenetratingBalm, ReconstructMasque, ThermMist, NourishOil, DetangleMist, LiquidMotion, InstantShine, ScalpRx, and NaturalControl. In addition, the company offers dry shampoo product in an aerosol spray formulation under the Psssssst brand; and a recipe for ageless skin under the Skin Appetit brand. It also markets its products at retail under the Heavy Duty, 40 Carrots, Virtual Laser, Stoppers-4, Bath Lounge, Vita-C2, Firminol-10, and TurboShave brands. The company markets its products to drug, food, and mass-merchandise retail chains through a team of internal sales managers, as well as a sales force of independent sales representatives. Its customers include chain drugstores, mass volume retailers, national mass merchandisers, and grocery chains. Nextera Enterprises, Inc. was founded in 1997 and is based in Panorama City, California.
Full NXRA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.